Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2003
10/09/2003CA2480568A1 Thiazol-2-yl-imine compounds as pde-7 inhibitors
10/09/2003CA2480386A1 Novel galactose transferases, peptides thereof and nucleic acid encoding the same
10/09/2003CA2480377A1 Drug microparticles
10/09/2003CA2480372A1 Combination therapy using trefoil peptides
10/09/2003CA2480358A1 Crystalline forms of rabeprazole sodium
10/09/2003CA2480352A1 Lansoprazole polymorphs and processes for preparation thereof
10/09/2003CA2480317A1 7-azaindoles as inhibitors of c-jun n-terminal kinases for the treatment of neurodegenerative disorders
10/09/2003CA2480270A1 Stabilized natural cannabinoid formulation
10/09/2003CA2480265A1 Cochleates made with purified soy phosphatidylserine
10/09/2003CA2480227A1 Neuroprotectant methods, compositions, and screening methods thereof
10/09/2003CA2480141A1 Oxygenating agents for enhancing host responses to microbial infections
10/09/2003CA2480106A1 Morpholinyl-urea derivatives for use of the treatment of inflammatory diseases
10/09/2003CA2480054A1 Pharmaceutical composition for preventing or treating respiratory disease
10/09/2003CA2480047A1 Use of rom production and release inhibitors to treat and prevent intraocular damage
10/09/2003CA2479995A1 Dispensing apparatus and cartridge
10/09/2003CA2479932A1 Piperazine substituted aryl benzodiazepines and their use as dopamine receptor antagonists for the treatment of psychotic disorders
10/09/2003CA2479930A1 Substituted tetrahydroisoquinolines as c5a receptor modulators
10/09/2003CA2479920A1 Microgel particles for the delivery of bioactive materials
10/09/2003CA2479915A1 Co-beadlet of dha and rosemary and methods of use
10/09/2003CA2479914A1 Meloxicam suppositories containing e.g. polyethylenglycol
10/09/2003CA2479912A1 Benzenesulphonate salt of a morpholine urea derivative for use as a ccr-3 antagonist in the treatment of inflammatory conditions
10/09/2003CA2479910A1 N-{ '(2s) -4- (3, 4-difluorobenzyl) morpholin-2yl]methyl} -2-{3-' (methylsulphonyl) amino] phenyl}acetamide as ccr3 antagonist for the treatment of inflammatory conditions
10/09/2003CA2479764A1 Hemiasterlin derivatives and uses thereof
10/09/2003CA2479744A1 Substituted 2,3-diphenyl pyridines
10/09/2003CA2479647A1 Human deubiquitinating protease gene on chromosome 7 and its murine ortholog
10/09/2003CA2479618A1 Spirocyclic amides as cannabinoid receptor modulators
10/09/2003CA2479495A1 Remedy for glioblastoma
10/09/2003CA2479453A1 Use of benzimidazole analogs in the treatment of cell proliferation
10/09/2003CA2479205A1 Azaindoles as inhibitors of c-jun n-terminal kinases
10/09/2003CA2478918A1 Angiogenesis inhibitors
10/09/2003CA2478502A1 Novel antiinfective compounds, process for their preparation and pharmaceutical compositions containing them
10/09/2003CA2478470A1 Solubilization of weak bases
10/09/2003CA2478389A1 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
10/09/2003CA2478154A1 Co-beadlet of dha and rosemary and methods of use
10/09/2003CA2478017A1 Therapeutic agent for glomerular disease
10/09/2003CA2477841A1 Method of use
10/09/2003CA2477764A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
10/09/2003CA2477751A1 Combinations of epinastine, belladonna and pseudoephedrine as new pharmaceutical formulations
10/09/2003CA2477734A1 Suramin and derivatives thereof as topical microbicide and contraceptive
10/09/2003CA2477265A1 Thiazolidine carboxamide derivatives as modulators of the prostaglandin f receptor
10/09/2003CA2476923A1 Method for treating cognitive disorders
10/09/2003CA2475202A1 Use of non-antibacterial tetracycline analogs and formulations thereof for the treatment of bacterial exotoxins
10/09/2003CA2448540A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/08/2003EP1351252A1 Erase scheme for non-volatile memory
10/08/2003EP1350854A1 Catalytic nucleic acid and its medical use
10/08/2003EP1350541A1 Use of dehydroepiandrosterone and an estradiol derivative for preparing a medicament for treating postmenopausal climacteric disorders
10/08/2003EP1350523A2 Therapeutic conjugates inhibiting vascular smooth muscle cells
10/08/2003EP1350522A1 Topical anesthesia compositions
10/08/2003EP1350518A1 Prolonged release of GM-CSF
10/08/2003EP1350514A2 Therapeutic use of cis-element decoys in vivo
10/08/2003EP1350513A1 Soft gelatine capsule comprising an 17-alpha-estradiol compound and ascorbic acid
10/08/2003EP1350512A1 Combinations of epinastine, belladonna and pseudoephedrine as new pharmaceutical formulations
10/08/2003EP1350511A1 Medicinal compositions containing aspirin
10/08/2003EP1350510A1 Use of agent for suppressing infection and proliferation of human immunodeficiency syndrome virus
10/08/2003EP1350509A1 Mucosal immunomodulator and use thereof
10/08/2003EP1350508A1 Antifungal formulation and the methods for manufacturing and using the same
10/08/2003EP1350435A2 Compositions and methods for promoting lipid assimilation in pets
10/08/2003EP1350262A2 Cpg-like nucleic acids and methods of use thereof
10/08/2003EP1349962A1 Methods and compositions for detecting polynucleotide duplex damage
10/08/2003EP1349936A2 Regulation of human b7-h2 protein
10/08/2003EP1349932A2 Novel human secreted proteins and polynucleotides encoding the same
10/08/2003EP1349928A2 A novel human g-protein coupled reciptor hgprbmy11 expressed highly in heart and variants thereof
10/08/2003EP1349927A2 Method for inhibiting the expression of a target gene and medicament for treating a tumor disease
10/08/2003EP1349909A1 A process for the preparation of a fat composition containing sterol esters a product obtained by said process and the use thereof
10/08/2003EP1349873A2 Modulation of il-2- and il-15-mediated t cell responses
10/08/2003EP1349865A2 Cobalt-porphyrin complexes and use thereof as an anti-obesity agent
10/08/2003EP1349864A2 Cyclic salen-metal compounds as scavengers for oxygen radicals and useful as antioxidants in the treatment and prevention of diseases
10/08/2003EP1349861A1 THIENO(3,2-d)PYRIMIDINES AND FURANO(3,2-d)PYRIMIDINES AND THEIR USE AS PURINERGIC RECEPTOR ANTAGONISTS
10/08/2003EP1349858A2 Agents useful for reducing amyloid precursor protein and treating demantia and methods of use thereof
10/08/2003EP1349857A1 Purine derivatives as purinergic receptor antagonists
10/08/2003EP1349856A2 Isoindolin-1-one glucokinase activators
10/08/2003EP1349855A1 5-'4-'2-(n-methyl-n- (2-pyridyl)amino)ethoxy!benzyl!thiazolidine-2, 4-dione mesylate salt
10/08/2003EP1349853A2 Antimicrobial quinolone derivatives and use of the same to treat bacterial infections
10/08/2003EP1349852A2 4-(hetero)aryl substituted indolinones
10/08/2003EP1349851A1 Compounds
10/08/2003EP1349850A1 Sodium channel modulators derived from 2-piperidylimidazoles
10/08/2003EP1349847A1 Oxybenzamides derivatives as factor xa inhibitors
10/08/2003EP1349846A1 Arylated furane and thiophene carboxylic acid amides with potassium channel blocking effect
10/08/2003EP1349843A1 Thiazole and oxazole derivatives as activators of human peroxisome proliferator activated receptors
10/08/2003EP1349842A1 1-dimercaptoalkylquinazolin-2,4(1h,3h)-diones as matrix metalloproteinase (mmp) inhibitors
10/08/2003EP1349841A2 Anilinopyrimidine derivatives as ikk inhibitors and compositions and methods related thereto
10/08/2003EP1349840A2 Anilinopyrimidine derivatives as jnk pathway inhibitors and compositions and methods related thereto
10/08/2003EP1349839A1 Phenylethenyl or phenylethinyl derivatives as glutamate receptor antagonists
10/08/2003EP1349837A1 Antitumoral carbazoles
10/08/2003EP1349836A2 Tetracyclic derivatives as spla2 inhibitors
10/08/2003EP1349835A2 (+)-1-(3,4-dichlorophenyl)-3-azabicyclo 3.1.0]hexane, compositions and uses thereof
10/08/2003EP1349834A2 Cycloalkyfused [g]-indole compounds as spla2-inhibitors in the treatment of inflammatory diseases
10/08/2003EP1349833A1 Indole and dihydroindole derivatives
10/08/2003EP1349832A2 Substituted benzoindoles as spla2 inhibitors
10/08/2003EP1349830A1 Tetralone derivatives as antitumor agents
10/08/2003EP1349614A2 Compounds regulating cell proliferation and differentiation
10/08/2003EP1349613A2 Thrombopoietin mimetics
10/08/2003EP1349580A1 Process to improve stability of a pharmaceutical composition
10/08/2003EP1349578A2 Medicinal association of a biguanine (metformin) and arginine
10/08/2003EP1349577A2 Intracellular delivery of charged therapeutic moieties to nerve cells by means of targeting proteins
10/08/2003EP1349574A2 Combination therapy using receptor tyrosine kinase inhibitors and angiogenesis inhibitors
10/08/2003EP1349567A1 Compositions containing gangliosides for use in the treatment of skin disorders
10/08/2003EP1349562A2 Inhibiting gs-fdh to modulate no bioactivity
10/08/2003EP1349560A2 Black tea extract for prevention of disease
10/08/2003EP1349558A1 Composition comprising melissa leaf extract for anti-angiogenic and matrix metalloproteinase inhibitory activity
1 ... 5317 5318 5319 5320 5321 5322 5323 5324 5325 5326 5327 5328 5329 5330 5331 5332 5333 5334 5335 5336 5337 ... 7860